Mass General Brigham Introduces AI-Driven Clinical Trial Screening Tool
Healthcare Finance News
|
Contributed by: Kate Gamble
Summary
Mass General Brigham has introduced AIwithCare, an AI-driven tool named RECTIFIER, aimed at streamlining patient eligibility assessment for clinical trials. Utilizing generative AI, RECTIFIER analyzes electronic health records and unstructured clinical notes to expedite the traditionally time-consuming manual review process. Currently in use across over 20 medical specialties such as cardiology and oncology, the tool has shown impressive accuracy rates in patient triage and urgent symptom identification. This innovation promises to enhance efficiency in clinical trial enrollment and reduce costs, thus potentially transforming eligibility determination practices for healthcare professionals.
